Manufacture of basic pharmaceutical products
CHIRON PHARMASYNTH AS
Revenue 2024
NOK 26.1m
Operating profit
NOK −722,000
Equity
NOK 18.9m
Incorporated
2001
Share capital
NOK 1.8m
Key figures · 2024
Current ratio
2.44
Equity ratio
59.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -2.8% | |
| Net margin (%%) | -1.0% | |
| Return on assets (%%) | -2.3% | |
| Likviditet | ||
| Current ratio | 2.44 | |
| Working capital | 18.9m | |
| Soliditet | ||
| Equity ratio (%%) | 59.0% | |
| Debt-to-equity ratio | 0.69 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.